Patents by Inventor Camilo Rey Ferro

Camilo Rey Ferro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition effective in preventing the adverse effects associated with the prolonged use of dihydrofolate reductase inhibitors
    Patent number: 10231974
    Abstract: The present invention relates to pharmaceutical compositions containing a combination of reduced forms of folate, liver protectors, vitamins, and essential or non-essential amino acids, useful in preventing the adverse effects associated with prolonged use of dihydrofolate reductase inhibitors.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: March 19, 2019
    Assignee: Companion Therapeutics, LLC
    Inventors: Julio César Villamil Torres, Camilo Rey Ferro
  • Pharmaceutical retinoid preparation for topical use
    Patent number: 9987239
    Abstract: The present invention relates to compositions and manufacturing methods of topical adapalene preparations, which include a solvent-lipid complex in order to keep the active pharmaceutical ingredient dissolved in a vehicle whose external or continuous phase is aqueous. Thus, a pleasant non-oily sensation is achieved at the moment of application, while greater retention of the active pharmaceutical ingredient is reached in targeted skin layers, thereby reducing systemic uptake in the blood.
    Type: Grant
    Filed: March 14, 2017
    Date of Patent: June 5, 2018
    Assignee: Rey Ventures, LLC
    Inventors: Julio César Villamil Torres, Camilo Rey Ferro
  • PHARMACEUTICAL COMPOSITION EFFECTIVE IN PREVENTING ADVERSE EFFECTS ASSOCIATED WITH THE USE OF GLUCOCORTICOIDS
    Publication number: 20180015122
    Abstract: The present invention relates to pharmaceutical compositions comprising combinations of amino acids, vitamins, and minerals, which prevent the occurrence of adverse effects associated with prolonged use of glucocorticoids (GCs), especially those of particular relevance due to their high frequency and potential debilitating effect for the patient. These effects are steroid myopathy, hyperglycemia and loss of bone mass.
    Type: Application
    Filed: July 14, 2016
    Publication date: January 18, 2018
    Inventors: Julio César Villamil Torres, Camilo Rey Ferro
  • Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors
    Patent number: 9855305
    Abstract: The present invention relates to a pharmaceutical composition containing a combination of vitamins, specific salts of calcium, magnesium, and iron, probiotics and prebiotics, which prevents the occurrence of adverse effects associated with long-term use of proton-pump inhibitors (PPIs). This effect is achieved by restoring all nutrient deficiencies and rectifying the intestinal flora imbalance caused by this type of drugs, particularly in patients with gastroesophageal reflux disease and Zollinger-Ellison syndrome.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: January 2, 2018
    Assignee: Companion Therapeutics LLC
    Inventors: Julio César Villamil Torres, Camilo Rey Ferro
  • PHARMACEUTICAL COMPOSITION EFFECTIVE IN PREVENTING THE ADVERSE EFFECTS ASSOCIATED WITH THE PROLONGED USE OF DIHYDROFOLATE REDUCTASE INHIBITORS
    Publication number: 20170319586
    Abstract: The present invention relates to pharmaceutical compositions containing a combination of reduced forms of folate, liver protectors, vitamins, and essential or non-essential amino acids, useful in preventing the adverse effects associated with prolonged use of dihydrofolate reductase inhibitors.
    Type: Application
    Filed: May 4, 2016
    Publication date: November 9, 2017
    Inventors: Julio César Villamil Torres, Camilo Rey Ferro
  • PHARMACEUTICAL COMPOSITION CONTAINING COMBINATIONS OF VITAMINS, MINERALS, PROBIOTICS, AND PREBIOTICS EFFECTIVE IN PREVENTING ADVERSE EFFECTS ASSOCIATED WITH THE USE OF PROTON-PUMP INHIBITORS
    Publication number: 20170281697
    Abstract: The present invention relates to a pharmaceutical composition containing a combination of vitamins, specific salts of calcium, magnesium, and iron, probiotics and prebiotics, which prevents the occurrence of adverse effects associated with long-term use of proton-pump inhibitors (PPIs). This effect is achieved by restoring all nutrient deficiencies and rectifying the intestinal flora imbalance caused by this type of drugs, particularly in patients with gastroesophageal reflux disease and Zollinger-Ellison syndrome.
    Type: Application
    Filed: March 29, 2016
    Publication date: October 5, 2017
    Inventors: Julio César Villamil Torres, Camilo Rey Ferro